GNMSF:OTCMKTS
Genmab
376,00 US$
0,00%
(0,00) 1 d
6 oct, 11:29:53 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de GNMSF...
Cap. burs.
23,00 mil M
Vol. medio
1,37 mil
Volumen
19,36 mil
Máximo en 52 sem.
396,97 US$
Mínimo en 52 sem.
232,50 US$
Beta
0,73
Acciones en circulación
62,41 M
N.º de empleados
3 mil
Cap. burs.
23,00 mil M
Vol. medio
1,37 mil
Volumen
19,36 mil
Máximo en 52 sem.
396,97 US$
Mínimo en 52 sem.
232,50 US$
Beta
0,73
Acciones en circulación
62,41 M
N.º de empleados
3 mil
Noticias
De fuentes web y partners de noticias
TipRanks
·
hace 1 día
Genmab Grants Restricted Stock Units to Board After Extraordinary General Meeting
Stock Titan
·
hace 1 día
Awarded cost-free, Genmab (GMAB)'s 5,300 board stock units vest after three years.
Investing.com
·
hace 1 día
H.C. Wainwright raises Genmab stock price target on positive trial data
TradingView
·
hace 3 días
European shares gain as Genmab jumps, bond yields retreat
Perfil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Acerca de Genmab